Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

GATIFLOXACIN

GATIFLOXACIN

Standard Dose
0.3%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview GATIFLOXACIN is listed in Drugs@FDA under application 203190 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient GATIFLOXACIN Form and strength SOLUTION; OPHTHALMIC - 0.3% Sponsor HI-TECH PHARMACAL Submission history Latest submission status date: 2014-04-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview GATIFLOXACIN is listed in Drugs@FDA under application 203190 (ANDA). Marketing status: None (Tentative Approval) Active ingredient GATIFLOXACIN Form and strength SOLUTION; OPHTHALMIC - 0.3% Sponsor HI-TECH PHARMACAL Submission history Latest submission status date: 2014-04-09 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.
GATIFLOXACIN (GATIFLOXACIN) | Drug Monograph | MedicHelpline